Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Coromandel International Limited (COROMANDEL.NS)
Secunderabad, IN
Established in 1961 and headquartered in Secunderabad, India, Coromandel International Limited is a leading Indian agricultural solutions provider. This subsidiary of E.I.D.-Parry (India) Limited focuses on the production and distribution of a wide array of farm inputs, operating primarily through its Nutrient and Other Allied Business, and Crop Protection divisions. Within its Nutrient segment, the company offers a comprehensive range of products, including phosphatic and single super phosphate fertilizers, specialty nutrients like bentonite sulphur, water-soluble and liquid fertilizers, and micronutrients, alongside organic nutri-booster solutions. The Crop Protection division delivers a suite of products designed to safeguard crops, encompassing insecticides, fungicides, herbicides, bio products, and plant growth regulators. Beyond manufacturing, Coromandel International provides essential farming services such as crop advisory, soil testing, and farm mechanization support. The company also maintains a significant retail presence, managing approximately 750 rural outlets across Andhra Pradesh, Telangana, and Karnataka. Its products are also distributed internationally through exports. The company was rebranded as Coromandel International Limited in September 2009, having previously been known as Coromandel Fertilisers Ltd.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.46% | -4.98% | -10.97% | -18.23% | -15.66% | -17.76% | -23.40% | +94.01% | +142.16% | +728.81% | +1,642.06% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 4 | 0 |
| Buy | 5 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Agricultural Inputs: +9.5%+30.7% ★ Q1'26: +20.4% (vs Q1'25)
-
EPS growth Agricultural Inputs: +23.0%-5.4% Q1'26: -75.9% (vs Q1'25)
-
FCF margin FCF growth · Agricultural Inputs: +27.6%+1.6% Q1'26: +21.0% (vs Q1'25)
-
EBIT margin Agricultural Inputs: +9.7%+8.5% Q1'26: +5.4% (vs Q1'25)
-
ROIC Agricultural Inputs: +7.4%+15.8% ★ Q1'26: +6.3% (vs Q1'25)
-
Share dilution Agricultural Inputs: +0.0%+0.1% Q1'26: 0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Agricultural Inputs: 0.03×0.47× ★ Q1'26: 0.77× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2010 actual |
Mar 2011 actual |
Mar 2012 actual |
Mar 2013 actual |
Mar 2014 actual |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 7 Rev. Ana. 8 EPS Ana. |
Mar 2027 9 Rev. Ana. 8 EPS Ana. |
Mar 2028 8 Rev. Ana. 8 EPS Ana. |
Mar 2029 2 Rev. Ana. 2 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
28.31B
est: 60.00B (-52.8%)
|
77.18B
est: 79.57B (-3.0%)
|
97.89B
est: 89.09B (+9.9%)
|
90.30B
est: 92.71B (-2.6%)
|
100.48B
est: 106.45B (-5.6%)
|
113.05B
est: 111.08B (+1.8%)
|
114.81B
est: 113.41B (+1.2%)
|
100.31B
est: 111.87B (-10.3%)
|
110.83B
est: 111.57B (-0.7%)
|
132.25B
est: 132.14B (+0.1%)
|
131.37B
est: 130.96B (+0.3%)
|
141.82B
est: 144.55B (-1.9%)
|
191.11B
est: 185.99B (+2.8%)
|
296.28B
est: 293.16B (+1.1%)
|
220.58B
est: 210.94B (+4.6%)
|
240.85B
est: 240.66B (+0.1%)
|
311.92B
302.76B – 323.22B
+29.6% YoY
|
329.84B
279.18B – 375.97B
+5.7% YoY
|
358.27B
297.46B – 425.94B
+8.6% YoY
|
366.52B
307.13B – 427.16B
+2.3% YoY
|
| EBITDA |
8.46B
est: 5.76B (+46.9%)
|
11.35B
est: 10.07B (+12.6%)
|
10.97B
est: 11.32B (-3.1%)
|
9.75B
est: 7.55B (+29.1%)
|
10.64B
est: 3.28B (+224.4%)
|
10.30B
est: 1.82B (+465.1%)
|
9.79B
est: 3.73B (+162.4%)
|
10.85B
est: 2.57B (+322.5%)
|
13.11B
est: 5.36B (+144.7%)
|
15.98B
est: 11.72B (+36.3%)
|
18.23B
est: 8.47B (+115.2%)
|
20.01B
est: 13.49B (+48.3%)
|
21.80B
est: 14.45B (+50.9%)
|
30.53B
est: 15.51B (+96.8%)
|
24.02B
est: 22.73B (+5.6%)
|
26.66B
est: 25.90B (+2.9%)
|
33.62B
32.63B – 34.83B
+29.8% YoY
|
35.55B
30.09B – 40.52B
+5.7% YoY
|
38.61B
32.06B – 45.90B
+8.6% YoY
|
39.50B
33.10B – 46.03B
+2.3% YoY
|
| EBIT |
7.87B
est: 5.89B (+33.6%)
|
10.73B
est: 9.39B (+14.2%)
|
10.32B
est: 10.37B (-0.5%)
|
9.05B
est: 12.14B (-25.5%)
|
9.69B
est: 10.39B (-6.7%)
|
9.27B
est: 10.07B (-7.9%)
|
8.73B
est: 9.36B (-6.8%)
|
9.84B
est: 9.01B (+9.2%)
|
12.12B
est: 9.73B (+24.5%)
|
14.84B
est: 14.56B (+1.9%)
|
17.01B
est: 14.50B (+17.3%)
|
18.65B
est: 18.75B (-0.5%)
|
20.46B
est: 20.08B (+1.9%)
|
29.11B
est: 21.56B (+35.0%)
|
22.16B
est: 20.74B (+6.8%)
|
24.25B
est: 23.63B (+2.6%)
|
30.67B
29.77B – 31.78B
+29.8% YoY
|
32.43B
27.45B – 36.97B
+5.7% YoY
|
35.23B
29.25B – 41.88B
+8.6% YoY
|
36.04B
30.20B – 42.00B
+2.3% YoY
|
| Net Income |
4.68B
est: 3.61B (+29.6%)
|
6.94B
est: 6.14B (+12.9%)
|
6.39B
est: 7.81B (-18.2%)
|
4.32B
est: 6.65B (-35.0%)
|
3.57B
est: 4.96B (-28.1%)
|
4.02B
est: 3.75B (+7.1%)
|
3.57B
est: 4.07B (-12.3%)
|
4.77B
est: 3.59B (+33.0%)
|
6.91B
est: 4.71B (+46.6%)
|
7.20B
est: 8.31B (-13.3%)
|
10.65B
est: 7.16B (+48.8%)
|
13.29B
est: 11.74B (+13.2%)
|
15.28B
est: 12.57B (+21.6%)
|
20.13B
est: 13.50B (+49.1%)
|
16.42B
est: 14.59B (+12.5%)
|
20.66B
est: 22.61B (-8.6%)
|
22.72B
21.29B – 24.14B
+0.5% YoY
|
23.57B
23.28B – 31.30B
+3.8% YoY
|
29.53B
27.24B – 34.86B
+25.3% YoY
|
37.80B
37.26B – 38.35B
+28.0% YoY
|
| SGA |
—
est: 860.92M (-100.0%)
|
—
est: 2.20B (-100.0%)
|
4.69B
est: 2.06B (+127.7%)
|
7.67B
est: 7.55B (+1.6%)
|
9.21B
est: 9.36B (-1.5%)
|
3.05B
est: 3.14B (-2.9%)
|
3.25B
est: 10.77B (-69.8%)
|
3.50B
est: 12.54B (-72.1%)
|
4.48B
est: 12.62B (-64.5%)
|
4.74B
est: 18.57B (-74.5%)
|
4.70B
est: 15.77B (-70.2%)
|
5.50B
est: 16.09B (-65.8%)
|
6.00B
est: 17.24B (-65.2%)
|
6.73B
est: 18.51B (-63.6%)
|
7.17B
est: 9.82B (-27.0%)
|
8.07B
est: 11.19B (-27.9%)
|
14.52B
14.09B – 15.04B
+29.8% YoY
|
15.35B
12.99B – 17.50B
+5.7% YoY
|
16.67B
13.84B – 19.82B
+8.6% YoY
|
17.06B
14.29B – 19.88B
+2.3% YoY
|
| EPS |
16.70
est: 16.12 (+3.6%)
|
24.66
est: 23.39 (+5.4%)
|
22.64
est: 24.12 (-6.1%)
|
15.27
est: 17.24 (-11.4%)
|
12.46
est: 14.51 (-14.1%)
|
13.80
est: 15.48 (-10.9%)
|
12.27
est: 13.15 (-6.7%)
|
16.36
est: 15.61 (+4.8%)
|
23.67
est: 25.52 (-7.3%)
|
24.64
est: 25.54 (-3.5%)
|
36.40
est: 33.90 (+7.4%)
|
45.34
est: 48.37 (-6.3%)
|
52.09
est: 49.96 (+4.3%)
|
68.51
est: 71.87 (-4.7%)
|
55.80
est: 49.58 (+12.6%)
|
70.23
est: 63.19 (+11.1%)
|
75.60
72.19 – 81.84
+19.6% YoY
|
90.68
78.90 – 106.11
+19.9% YoY
|
108.84
92.33 – 118.18
+20.0% YoY
|
128.15
126.29 – 130.01
+17.7% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-08 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-07 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-05 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-28 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-27 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-24 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-15 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Arun Alagappan | Executive Chairman | 103M | male |
| S. Sankarasubramanian ICWA | MD, Chief Executive Officer & Additional Director | 45M | male |
| Arunachalam Vellayan | Whole-Time Director of Corporate & Strategic Planning | 43M | male |
| Narayanan Vellayan | Executive Director of Nutrient Business | 43M | male |
| Madhab Adhikari | SVP, Head of Sales & Marketing for Fertilisers and SSP | — | male |
| Sanjay Prakash Sinha | Executive Vice President of IT & Chief Information Officer | — | male |
| Shanmugasundaram | Company Secretary & Compliance Officer | — | male |
| Ambadasu Ramachandra Rao | Senior Vice President of Projects | — | male |
| Venkateswaran | Vice President & Head of Internal Audit and Chief Risk Officer | — | male |
| Amit Rastogi | Executive VP & Chief Technology Officer | — | — |
| Arun Leslie George | President & Chief Human Resources Officer | — | male |
| Deepak Natarajan | Chief Financial Officer | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for COROMANDEL.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
